Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Follow JNM on Twitter
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Subscribe to our RSS feeds

More articles from SNMMI Newsline

  • You have access
    SNMMI Leadership Update: SNMMI’s Role in the Nuclear Medicine Renaissance
    Richard L. Wahl
    Journal of Nuclear Medicine May 1, 2022, 63 (5) 16N-17N;
  • You have access
    From the Literature
    Journal of Nuclear Medicine May 1, 2022, 63 (5) 20N-24N;
  • You have access
    Newsbriefs
    Journal of Nuclear Medicine May 1, 2022, 63 (5) 18N-19N;
  • You have access
    ASNC/SNMMI Radionuclide Authorized User Training Course
    Journal of Nuclear Medicine May 1, 2022, 63 (5) 15N;
  • You have access
    Updates to Appropriate Use Criteria for PSMA PET
    Thomas A. Hope and Hossein Jadvar
    Journal of Nuclear Medicine May 1, 2022, 63 (5) 14N;
  • You have access
    SNMMI Newsline
    Journal of Nuclear Medicine May 1, 2022, 63 (5) 13N-24N;
  • You have access
    FDA Approves Pluvicto/Locametz for Metastatic Castration-Resistant Prostate Cancer
    Journal of Nuclear Medicine May 1, 2022, 63 (5) 13N;
  • You have access
    NRC Vetoes T&E Changes; Approves 82Rb and Emerging Tech Modernization
    Journal of Nuclear Medicine April 1, 2022, 63 (4) 16N;
  • You have access
    SNMMI Newsline
    Journal of Nuclear Medicine April 1, 2022, 63 (4) 15N-26N;
  • You have access
    Medical Societies Seek Medicare Reform Collaboration
    Journal of Nuclear Medicine April 1, 2022, 63 (4) 15N;

Pages

  • Next
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • …
  • 74
SNMMI

© 2022 Journal of Nuclear Medicine

Powered by HighWire